Anthrogen
PrivateLast Round
Seed
Nov 12, 2024
Total Funding Raised
$4.5M
Company Overview
Anthrogen operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in November 2024.
Anthrogen is a bioengineering company that operates a platform to generate molecular machines for applications in human health, carbon capture, and industrial manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anthrogen Comparables
Compare Anthrogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chan Zuckerberg Biohub | 92% | |
| 310.ai | 89% | |
| OpenProtein.AI | 85% |
For institutional investors. Book with your work email.
Anthrogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2024 | ||||
| Pre Seed | Jun 7, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Anthrogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Ritual Capital | Seed |
| Wayfinder Ventures | Seed |
| Regenerative Ventures Holdings | Seed |
| Todd & Rahul Capital | Seed |
| Wayfinder Ventures | Seed |
| Ritual Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
Launched Odyssey, a 102B parameter model using Consensus and discrete diffusion.
- Nov 12, 2024
$4M raised in Seed round.
For institutional investors. Book with your work email.
Anthrogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anthrogen's valuation, stock price, and market status.
Is Anthrogen a public or private company?
Anthrogen is a private company.
What is the current stock price of Anthrogen?
Anthrogen is a private company, so its shares have no public market price. Caplight tracks Anthrogen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anthrogen worth (valuation)?
Valuation information for Anthrogen is not publicly available.
Can I buy Anthrogen stock?
Anthrogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anthrogen's last funding round?
Anthrogen's most recent funding round was Seed on November 12, 2024.
Who are the main investors in Anthrogen?
Key investors in Anthrogen include Regenerative Ventures Holdings, BoxGroup, ReGen Ventures.
Will Anthrogen IPO soon?
No public IPO plans have been announced for Anthrogen.
How can I track Anthrogen secondary market activity?
Caplight tracks bids, offers, and trades in Anthrogen's shares on secondary markets.